Nuanwa Technology (暖哇科技) makes a second push for a Hong Kong listing — how solid is its claim as the "first Insurance AI stock"?

Nuanwa Technology (暖哇科技), an insurance-AI firm incubated by ZhongAn Online (众安在线) and backed by Sequoia Capital (红杉资本), has reportedly refiled a prospectus with the Hong Kong Stock Exchange less than a month after an earlier filing lapsed. The company leads China’s insurance-AI pack by scale — Frost & Sullivan (弗若斯特沙利文) data show it handled the most insurer cases among independent AI vendors in 2024 and by end‑2025 its solutions were used by 115 insurers — but the finances complicate the narrative. Can a firm portrayed as the industry's vanguard also prove it can stand independently and deliver sustainable profits?

Financials tell a mixed story. Revenue rose from RMB 655m (6.55亿元) in 2023 to RMB 1.024bn (10.24亿元) in 2025, but net losses over 2023–25 totaled more than RMB 660m, with a 2025 net loss of RMB 270m. Adjusted net profit has been positive for three years, but that metric’s growth decelerated sharply in 2025 and depends on accounting adjustments tied to preferred‑share fair‑value changes. Gross margin slid from 58.3% in 2023 to 47.2% in 2025, cash and equivalents stood at RMB 247m (2.47亿元) against current liabilities of RMB 1.963bn (19.63亿元), leaving a net current‑liability gap of roughly RMB 1.18bn — all of which helps explain why an IPO raise is pressing.

The market opportunity is big but contested. China’s insurance‑AI total addressable market was RMB 746.8bn in 2024 and is projected to expand, and health‑insurance AI in particular shows rapid forecasted growth. Yet structural risks are acute: Nuanwa remains highly dependent on its incubator, ZhongAn Online — which is simultaneously its 31.65% shareholder, largest single customer and an increasingly capable AI competitor. From 2023–25 ZhongAn accounted for between 61.8% and 43.3% of Nuanwa’s revenue; top‑five client concentration likewise remains elevated. At the same time, major insurers and platforms are accelerating in‑house AI programs — a trend intensified by broader tech geopolitics and export controls that have pushed Chinese firms toward self‑reliance in core models and compute.

So is Nuanwa truly the “first Insurance AI stock”? It has the tech stack, a large knowledge base and strong client metrics in specific scenarios — high cross‑sell and retention rates suggest product‑market fit in places. But can it convert project‑level wins into scalable, margin‑sustaining revenue streams independent of ZhongAn, and can planned uses of IPO proceeds (it has been reported that about 30% would target strategic M&A) close that gap? The answer will determine whether investors view Nuanwa as a genuine independent industry leader or essentially an extension of an insurer‑incubator — and that judgment will set the valuation ceiling for this second Hong Kong push.